Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06378567 · ClinicalTrials.gov registry record · NA
A Study to Assess the Effects of Dietary Supplement Drinks on Sleep, Stress and Mood
A NA study of Stress and Sleep, sponsored by The Water Street Collective.
- Completed
- Registry status
- NA
- Development phase
- 176
- Enrollment target
- 1
- Study location
NCT06378567: Completed NA study of Stress and Sleep, sponsored by The Water Street Collective.
NCT06378567 is a NA study of Stress and Sleep that has completed, run by The Water Street Collective. The registered enrollment target is 176 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06378567, a NA study of Stress and Sleep, has completed, sponsored by The Water Street Collective.
- COMPLETED
- Registry status
- NA
- Development phase
- 176 participants
- Enrollment target
- 1
- Study location
Study Summary
A home placement, randomized, double blind, placebo-controlled, study to determine the effect of dietary liquid shot beverage products on self-reported measures of sleep, stress and mood on generally healthy participants with current self-reported mild/moderate sleep difficulties (but not clinical insomnia) and mild/moderate stress.
Primary Outcome
Change in Patient-Reported Outcomes Measurement Information Systems (PROMIS) - Sleep disturbance 8A Scores range from 8-40, where lower scores indicate lower sleep disturbance
Interventions
- DIETARY_SUPPLEMENT Dietary supplement liquid shot beverage products
Study Locations (1)
Georgia
- Sago Atlanta - The Palisades Complex - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2024-08-05 |
| Est. Completion | 2024-09-01 |
| Phase | NA |
What the finished NCT06378567 record still lists
NCT06378567 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 152 other Stress trials with a reported enrollment target (78% lower).
The record links to 3 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which Dietary supplement liquid shot beverage products is the first listed.
NCT06378567 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06378567 about?
NCT06378567 is a clinical study titled "A Study to Assess the Effects of Dietary Supplement Drinks on Sleep, Stress and Mood". A home placement, randomized, double blind, placebo-controlled, study to determine the effect of dietary liquid shot beverage products on self-reported measures of sleep, stress and mood on generally healthy participants with current self-reported mild/moderate sleep difficulties (but not clinical i...
What is the current status of trial NCT06378567?
This trial is currently completed. It is a NA study. The enrollment target is 176 participants. The study started on 2024-08-05. Estimated completion is 2024-09-01.
What conditions does trial NCT06378567 study?
This clinical trial studies the following conditions: Stress, Sleep, Mood.
What interventions are being tested in trial NCT06378567?
The interventions under investigation include: Dietary supplement liquid shot beverage products (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06378567?
This trial is sponsored by The Water Street Collective, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06378567 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06378567's enrollment target sits among peer trials
176 34th of 152 higher than 119 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI